FDA Inspection 818340 — Takeda Pharmaceuticals USA, Inc.

Takeda Pharmaceuticals USA, Inc. — FEI 3002393210

The FDA completed an inspection of Takeda Pharmaceuticals USA, Inc. on January 28, 2013 in Deerfield, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 28, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Deerfield, IL (United States)

Additional Details

Sponsor, Contract Research Organization